US EditionBreakthrough: New Diet Pill Will Surpass Wegovy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
For the first time, an anti-obesity drug conceived, developed and tested in South America successfully surpasses the initial phase of human testing. It is Sana, a remedy created by the biotechnology company Eolo Pharma, based in Uruguay, and supported by the prestigious Institut Pasteur de Montevideo. “We think of this drug from scratch to treat obesity and associated diseases such as type 2 diabetes,” explained researcher Carlos Escande, one of…
The fight against obesity is undergoing an accelerated transformation stage. Over the past few years, medicines such as Ozempic and Wegovy, belonging to the class of GLP-1 receptor agonists, have gained notoriety by their ability to induce weight loss by reducing appetite. However, a new pharmacological proposal is attracting the attention of the scientific community: an experimental pill that burns fat without suppressing appetite. What is this…
NEWS FROM THE RESEARCH FRONT: Every week, Ekstra Bladet takes you on a tour of the research corridor, where we review the most important results for you and your health. This time it is about researchers having developed a new weight loss pill that can surpass both slimming injections and bariatric surgeries. At the same time, another research team has found an invisible layer of sugar in the brain, which may be the key to stopping dementia
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
